Alan Broughton

1.2k total citations
40 papers, 956 citations indexed

About

Alan Broughton is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Alan Broughton has authored 40 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 12 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Alan Broughton's work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Synthesis and Biological Evaluation (7 papers). Alan Broughton is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Synthesis and Biological Evaluation (7 papers). Alan Broughton collaborates with scholars based in United States, United Kingdom and Germany. Alan Broughton's co-authors include Jack D. Thrasher, James E. Strong, Roberta Madison, Wan-Fen Fang, Eugene D. Jacobson, G.F. Heuser, Stanley T. Crooke, Lawrence H. Einhorn, Paul Y. Holoye and Gerald P. Bodey and has published in prestigious journals such as Circulation Research, Cancer and Environmental Health Perspectives.

In The Last Decade

Alan Broughton

40 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Broughton United States 18 231 193 141 131 129 40 956
David S. Newcombe United States 20 287 1.2× 191 1.0× 64 0.5× 64 0.5× 79 0.6× 41 879
Patrick Koch Germany 19 191 0.8× 91 0.5× 61 0.4× 63 0.5× 101 0.8× 34 1.2k
B. M. Hannigan United Kingdom 17 224 1.0× 53 0.3× 170 1.2× 72 0.5× 57 0.4× 41 1.2k
Arthur L. Sagone United States 23 408 1.8× 111 0.6× 71 0.5× 34 0.3× 114 0.9× 51 1.7k
W. FRAIN-BELL United Kingdom 24 203 0.9× 174 0.9× 49 0.3× 85 0.6× 29 0.2× 68 1.4k
E J Kelly United Kingdom 12 325 1.4× 63 0.3× 653 4.6× 67 0.5× 183 1.4× 16 1.5k
Angelo Burlina Italy 16 199 0.9× 50 0.3× 93 0.7× 44 0.3× 303 2.3× 89 1.1k
Stuart Levin United States 16 273 1.2× 96 0.5× 35 0.2× 33 0.3× 133 1.0× 41 913
Ibert C. Wells United States 19 216 0.9× 55 0.3× 90 0.6× 46 0.4× 87 0.7× 42 1.0k
H. Keberle Switzerland 13 240 1.0× 49 0.3× 69 0.5× 89 0.7× 40 0.3× 35 1.1k

Countries citing papers authored by Alan Broughton

Since Specialization
Citations

This map shows the geographic impact of Alan Broughton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Broughton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Broughton more than expected).

Fields of papers citing papers by Alan Broughton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Broughton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Broughton. The network helps show where Alan Broughton may publish in the future.

Co-authorship network of co-authors of Alan Broughton

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Broughton. A scholar is included among the top collaborators of Alan Broughton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Broughton. Alan Broughton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thrasher, Jack D., G.F. Heuser, & Alan Broughton. (2002). Immunological Abnormalities in Humans Chronically Exposed to Chlorpyrifos. Archives of Environmental Health An International Journal. 57(3). 181–187. 72 indexed citations
2.
Thrasher, Jack D., Roberta Madison, & Alan Broughton. (1993). Immunologic Abnormalities in Humans Exposed to Chlorpyrifos: Preliminary Observations. Archives of Environmental Health An International Journal. 48(2). 89–93. 101 indexed citations
3.
Madison, Roberta, Alan Broughton, & Jack D. Thrasher. (1991). Immunologic biomarkers associated with an acute exposure to exothermic byproducts of a ureaformaldehyde spill.. Environmental Health Perspectives. 94. 219–223. 18 indexed citations
4.
Thrasher, Jack D., Alan Broughton, & Roberta Madison. (1990). Immune Activation and Autoantibodies in Humans with Long-Term Inhalation Exposure to Formaldehyde. Archives of Environmental Health An International Journal. 45(4). 217–223. 62 indexed citations
5.
Thrasher, Jack D., et al.. (1989). Building‐related illness and antibodies to albumin conjugates of formaldehyde, toluene diisocyanate, and trimellitic anhydride. American Journal of Industrial Medicine. 15(2). 187–195. 17 indexed citations
6.
Thrasher, Jack D., et al.. (1988). Antibodies and immune profiles of individuals occupationally exposed to formaldehyde: Six case reports. American Journal of Industrial Medicine. 14(4). 479–488. 31 indexed citations
7.
Broughton, Alan, et al.. (1988). Immunological evaluation of four arc welders exposed to fumes from ignited polyurethane (isocyanate) foam: Antibodies and immune profiles. American Journal of Industrial Medicine. 13(4). 463–472. 23 indexed citations
8.
Duffy, Michael, Jack D. Thrasher, Alan Broughton, et al.. (1988). CLINICAL COMMENTS. Clinical Gerontologist. 7(3-4). 57–85. 1 indexed citations
9.
Knight, James, et al.. (1983). Clinical pharmacology of the anticancer polypeptide neocarzinostatin. Cancer Chemotherapy and Pharmacology. 10(3). 200–4. 2 indexed citations
10.
Elson, Michael K., Martin M. Oken, Rex B. Shafer, et al.. (1978). Comparison of two radioimmunoassays and a microbiologic assay for bleomycin. Medical and Pediatric Oncology. 5(1). 213–218. 6 indexed citations
11.
Alberts, David S., Kenneth J. Himmelstein, Michael Mayersohn, et al.. (1978). Bleomycin pharmacokinetics in man. Cancer Chemotherapy and Pharmacology. 1(3). 177–81. 54 indexed citations
12.
Hall, S. W., Alan Broughton, James E. Strong, & Robert S. Benjamin. (1977). Clinical pharmacology of bleomycin by radioimmunoassay. Clinical research. 25(3). 5 indexed citations
13.
Broughton, Alan, et al.. (1977). Specificity of antisera produced against bleomycin.. PubMed. 61(8). 1509–12. 7 indexed citations
14.
Crooke, Stanley T., Robert L. Comis, Lawrence H. Einhorn, et al.. (1977). Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus.. PubMed. 61(9). 1631–6. 41 indexed citations
15.
Broughton, Alan, James E. Strong, Paul Y. Holoye, & Carlos Bedrossian. (1977). Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay. Cancer. 40(6). 2772–2778. 38 indexed citations
16.
Broughton, Alan & James E. Strong. (1976). Radioimmunoassay of iodinated gentamicin. Clinica Chimica Acta. 66(1). 125–129. 26 indexed citations
17.
Broughton, Alan, et al.. (1975). Drug Screening by Enzymatic Immunoassay with the Centrifugal Analyzer. Clinical Chemistry. 21(2). 186–189. 10 indexed citations
18.
Broughton, Alan. (1975). Application of Adrenocorticotropin Assays in a Routine Clinical Laboratory. American Journal of Clinical Pathology. 64(5). 618–624. 5 indexed citations
19.
Broughton, Alan & J Pitts. (1973). An inexpensive continuous flow four-channel analyzer system.. PubMed. 30(2). 151–5. 1 indexed citations
20.
Broughton, Alan, et al.. (1967). Tropical Otomycosis. The Journal of Laryngology & Otology. 81(9). 987–997. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David S. Newcombe Breakdown of academic impact, for papers by Patrick Koch Breakdown of academic impact, for papers by B. M. Hannigan Breakdown of academic impact, for papers by Arthur L. Sagone Breakdown of academic impact, for papers by W. FRAIN-BELL Breakdown of academic impact, for papers by E J Kelly Breakdown of academic impact, for papers by Angelo Burlina Breakdown of academic impact, for papers by Stuart Levin Breakdown of academic impact, for papers by Ibert C. Wells Breakdown of academic impact, for papers by H. Keberle
Rankless by CCL
2026